PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

Item

http://www.wikidata.org/entity/Q41911186

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

@en

type

Item

label

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

@en

prefLabel

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

@en

P1476

PPARα-Independent Arterial Smooth Muscle Relaxant Effects of PPARα Agonists.

@en

P2093

Jon Andresen

http://www.w3.org/2001/XMLSchema#string

Michael J Wacker

http://www.w3.org/2001/XMLSchema#string

Mostafa Badr

http://www.w3.org/2001/XMLSchema#string

Neerupma Silswal

http://www.w3.org/2001/XMLSchema#string

Nikhil K Parelkar

http://www.w3.org/2001/XMLSchema#string

P2860

Targeted disruption of the alpha isoform of the peroxisome proliferator-activated receptor gene in mice results in abolishment of the pleiotropic effects of peroxisome proliferators

Activation of the peroxisome proliferator-activated receptor alpha protects against myocardial ischaemic injury and improves endothelial vasodilatation.

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

Expression of peroxisome proliferator-activated receptor alpha (PPAR alpha) in primary cultures of human vascular endothelial cells

Peroxisome proliferator-activated receptor (PPAR)-alpha: a pharmacological target with a promising future

Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators

Endothelium-dependent vasodilator effects of peroxisome proliferator-activated receptor beta agonists via the phosphatidyl-inositol-3 kinase-Akt pathway

Dependence of peroxisome proliferator-activated receptor ligand-induced mitogen-activated protein kinase signaling on epidermal growth factor receptor transactivation

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial

P304

302495

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2012/302495

http://www.w3.org/2001/XMLSchema#string

P478

2012

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231176678

http://www.w3.org/2001/XMLSchema#string

P698

23008696

http://www.w3.org/2001/XMLSchema#string

P921

GW7647

P932

3447381

http://www.w3.org/2001/XMLSchema#string